What this study is
The overall objective of this study is to determine the feasibility of identifying transdiagnostic biomarkers of cognitive function mediated by neuromodulation of the dorsolateral prefrontal cortex that are translatable across disease groups in order to more accurately phenotype clusters of cognitive dysfunction. Completing behavioral paradigms with electrophysiology and TMS is a challenging frontier. This study focuses on the feasibility of such an endeavor for those with chronic pain or depression as well as healthy controls.
What's being tested
- Computer game/task
Intervention · BEHAVIORAL
N-back, COGED, PacMan game, Bandit task, Websurf task.
- Health surveys online
Intervention · BEHAVIORAL
Health surveys to study themes like pain, sleep, depression and anxiety, and PTSD.
Study details
- Sponsor
- University of Minnesota
- Conditions
- Pain · Depression
- Enrolling
- 48 people
- Starts
- 2022-04-11
- Est. completion
- 2027-03-01
- Design
- Open-label, non-randomized, single group
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years and overSex ALLHealthy volunteers AcceptedYou may qualify if
- Arm 1, healthy controls:
- Have access to the online study platform.
- Pain or depression
You can't join if
- Under 18, non-English speaking Arm 2: pain and depression:
- Pregnant women
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (1)
1 openUniversity of Minnesota
Minneapolis, Minnesota, United States
- David Darrow · Contact612-946-1424hdlab@umn.edu
Recruiting
Study team
Sponsor
University of Minnesota
Study ID NEUR-2020-29420
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.